Metamizolnatrij Hidrat Bausch Health (Metamizole Sodium Monohydrate)

The drug works by non‑selectively inhibiting cyclooxygenase enzymes, reducing prostaglandin production, and by modulating central pain pathways in the spinal cord and brain. These actions together provide analgesic and antipyretic effects, while also influencing opioid and cytokine pathways.

The appropriate dose of Metamizole Sodium Monohydrate is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, age, and renal or hepatic function. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for Metamizole Sodium Monohydrate in pregnancy and lactation are limited, and the pregnancy category is listed as unknown. It should only be used during pregnancy or while breastfeeding if the potential benefit justifies the potential risk, and under close medical supervision.

To order Metamizolnatrij, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metamizole belongs to the pyrazolone class and offers strong analgesic and antipyretic effects, often comparable to high‑dose NSAIDs but with a different safety profile. Unlike opioids, it does not act on opioid receptors, and unlike some NSAIDs, it may have a lower risk of gastrointestinal ulceration but carries a rare risk of agranulocytosis.

Metamizole should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme heat or humidity to maintain stability.

Metamizole Sodium Monohydrate is administered orally, typically as tablets or oral solution, according to the prescriber’s directions. The medication should be swallowed with water and taken with or without food as advised by the healthcare professional.

The most serious adverse reactions include agranulocytosis, a potentially life‑threatening drop in white blood cells, and severe allergic responses such as anaphylaxis or Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they develop signs of infection, rash, or breathing difficulties.

Metamizole is contraindicated in individuals with a known hypersensitivity to pyrazolones, a history of agranulocytosis or other severe blood dyscrasias, and in patients with severe hepatic or renal impairment unless closely monitored. It should also be avoided in children unless specifically prescribed by a qualified clinician.